These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 9203372

  • 21. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
    Marti A, Jichlinski P, Lange N, Ballini JP, Guillou L, Leisinger HJ, Kucera P.
    J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
    [Abstract] [Full Text] [Related]

  • 22. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K, Brooke RC, Farrar W, Rhodes LE.
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
    Berg K, Anholt H, Bech O, Moan J.
    Br J Cancer; 1996 Sep; 74(5):688-97. PubMed ID: 8795569
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
    van Den Boogert J, van Staveren HJ, de Bruin RWF, de Rooij FWM, Edixhoven-Bosdijk A, Siersema PD, van Hillegersberg R.
    J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
    Calin MA, Gruia Ml, Herascu N, Coman T.
    J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
    [Abstract] [Full Text] [Related]

  • 31. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
    Qin J, Zhou C, Zhu M, Shi S, Zhang L, Zhao Y, Li C, Wang Y, Wang Y.
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
    [Abstract] [Full Text] [Related]

  • 32. Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy.
    Nomoto T, Komoto K, Nagano T, Ishii T, Guo H, Honda Y, Ogura SI, Ishizuka M, Nishiyama N.
    Cancer Sci; 2023 Mar; 114(3):1086-1094. PubMed ID: 36341512
    [Abstract] [Full Text] [Related]

  • 33. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
    Gerscher S, Connelly JP, Beijersbergen Van Henegouwen GM, MacRobert AJ, Watt P, Rhodes LE.
    Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
    [Abstract] [Full Text] [Related]

  • 34. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
    Iinuma S, Bachor R, Flotte T, Hasan T.
    J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
    [Abstract] [Full Text] [Related]

  • 35. Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA.
    Van Staveren HJ, Beek JF, Verlaan CW, Edixhoven A, De Reijke TM, Brutel De La RiviERe G, Star WM.
    Lasers Med Sci; 2002 Mar; 17(4):238-45. PubMed ID: 12417977
    [Abstract] [Full Text] [Related]

  • 36. 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration.
    van den Boogert J, van Hillegersberg R, de Rooij FW, de Bruin RW, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JH, Tilanus HW.
    J Photochem Photobiol B; 1998 Jun 15; 44(1):29-38. PubMed ID: 9745726
    [Abstract] [Full Text] [Related]

  • 37. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB, Choi JY, Chun JS, Yun SJ, Lee SC, Oh J, Park HR.
    Br J Dermatol; 2008 Jul 15; 159(1):61-7. PubMed ID: 18489589
    [Abstract] [Full Text] [Related]

  • 38. Protoporphyrin-IX distribution and photodynamic effect in rat oesophagus after aminolaevulinic acid administration.
    Mäkinen K, Grönlund-Pakkanen S, Tiirikainen M, Nuutinen P, Kuusisto A, Alhava E.
    Scand J Gastroenterol; 1997 Jul 15; 32(7):633-7. PubMed ID: 9246700
    [Abstract] [Full Text] [Related]

  • 39. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
    Zhang J, Yuan S, Fan M, Wang K, Guo J, Zang A, Ren J, Su W, Zhang C, Xie Y.
    Bioorg Med Chem; 2024 May 01; 105():117726. PubMed ID: 38626642
    [Abstract] [Full Text] [Related]

  • 40. A comparative study on the enhancement efficacy of specific and non-specific iron chelators for protoporphyrin IX production and photosensitization in HaCat cells.
    Xia Y, Huang Y, Lin L, Liu X, Jiang S, Xiong L.
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec 01; 29(6):765-70. PubMed ID: 20037824
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.